CTRI/2020/07/026840
Completed
N/A
A Prospective Randomized Controlled Clinical Trial to evaluate the Efficacy and Safety of Guduchi Ghan Vati in the management of COVID-19 infection.
Directorate of AYUSH Government of Madhya Pradesh0 sites30 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Directorate of AYUSH Government of Madhya Pradesh
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Mild to moderate cases registered in the Hospital,
- •above 18 years of age, with COVID 2019 (Confirmed by
- •RT\-PCR) quarantined at identified hospital set up.
- •Participants who can take medicines orally.
- •Patients willing to provide signed informed consent.
Exclusion Criteria
- •Cases of severe vomiting which would make oral administration of medicine difficult.
- •Cases of respiratory failure and requiring mechanical ventilation.
- •Alanine Transaminase (ALT) or Aspartate Transaminase (AST) \> 2 times the upper limit of normal.
- •Patients with COVID 19 in critical condition or ARDS or NIAD 8 â??point ordinal score 2 Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation
- •Pregnant or lactating women
- •Any other condition, which as per the investigator would jeopardize the outcome of the trial.
- •Withdrawal Criteria:
- •a) The participant may be withdrawn from the trial if there is
- •Any major ailment which necessitating the institution of new modalities of treatment.
- •Non\-compliance of the treatment regimen (minimum 80% compliance is essential to continue in the study).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
A Prospective Randomized Controlled Clinical Trial of Prophylactic Cranial Irradiation in Metastatic HER-2 positive Breast Cancer.Metastatic HERDŽ positive breast cancer patientsRisk of brain metastasisPCIHER2 positiveMetastatic breast cancerTCTR20170612001Ratchadapiseksompotch research fund235
Completed
Phase 2
To observe the effect of Ayurvedic medicine (Ashwagandha and Shunti) for the treatment of COVID-19Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/08/027224Central Council for Research in Ayurvedic Sciences New Delhi48
Completed
N/A
Comparing Two Different Regional Anaesthetic Techniques With Standard IV Analgesic Technique For Post-Operative Pain Management In Patients Undergoing Laproscopic Cholecystectomy.Health Condition 1: O- Medical and SurgicalCTRI/2023/03/050416ABHINAV NANDA111
Completed
N/A
Communication management: a trial comparing two strategies for information communication to patientsISRCTN01508870Donostia University Hospital (Hospital Universitario Donostia) (Spain)30
Not Yet Recruiting
Phase 2
To assess the clinical efficacy of Ayurvedic interventions in managing asymptomatic to mild cases of COVID-19Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/08/027346Shri Dhanwantry ayurevdic college and hospital